Skip to main content

Our HPV Vaccination Initiatives

We work at the national and community level to increase HPV vaccination uptake. Our initiatives seek to advance best practices, increase collaboration, and provide leadership.

National HPV Vaccination Roundtable

The National HPV Vaccination Roundtable, established by the American Cancer Society (ACS) and the Centers for Disease Control and Prevention (CDC) in 2014, is a national coalition of public organizations, private organizations, voluntary organizations, and invited individuals dedicated to reducing the incidence of and mortality from HPV-associated cancer in the U.S., through coordinated leadership and strategic planning. 

Get more information about the National HPV Vaccination Roundtable >>

HPV VACs Program 

The American Cancer Society’s HPV VACs (Vaccinate Adolescents against Cancers) Program is growing and leading HPV vaccination efforts with a focus on improving adolescent HPV vaccination rates across the nation. The VACs program engages health systems, payors, federally qualified health centers (FQHCs), state health departments, and other state-based partners to increase HPV vaccination through clinic-level interventions, quality improvement efforts, provider education, and system-wide process changes to increase the availability and utilization of the HPV vaccine. 

Mission: HPV Cancer Free

The American Cancer Society’s Mission: HPV Cancer Free is a public health initiative to eliminate vaccine-preventable HPV cancers as a public health problem, starting with cervical cancer. Our goal is to reach an annual vaccination rate of 80% of 13-year-olds in the United States by 2026.

To do this we are:

  • Facilitating provider training and education.
  • Engaging critical stakeholders and partners to drive vaccination rate improvement.
  • Influencing stakeholders to use relevant data to drive planning and impact.
  • Leading and supporting HPV vaccination interventions with health systems.
  • Increasing parental knowledge about the vaccine through news, digital, and social media platforms and by mobilizing our ACS volunteer network and ACS volunteers to share science-based information about the vaccine.